These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26727454)

  • 1. High-dose methotrexate-based chemotherapy as treatment for histiocytic sarcoma of the central nervous system.
    Curry RC; Faivre G; Akkari L; Joyce JA; Lin O; Rosenblum M; Diamond EL; Fisher R; Omuro A
    Leuk Lymphoma; 2016 Aug; 57(8):1961-4. PubMed ID: 26727454
    [No Abstract]   [Full Text] [Related]  

  • 2. Methotrexate- and/or cytarabine-based chemotherapy may be effective and safe in solid-organ transplant recipients with primary central nervous system lymphomas.
    Moise L; Matta C; Hanna C; Pilorge S; Fermé C; Durrbach A; Ribrag V
    Leuk Lymphoma; 2011 Mar; 52(3):521-4. PubMed ID: 21133726
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of lymphohistiocytic erythrophagocytosis with VP-16 and aziridinylbenzoquinone.
    Becton DL; Kurtzberg J; Kinney TR; Friedman HS; Chaffee S; Falletta JM
    Med Pediatr Oncol; 1987; 15(2):58-61. PubMed ID: 3108638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate-cytarabine-dexamethasone combination chemotherapy with or without rituximab in patients with primary central nervous system lymphoma.
    Sun X; Liu J; Wang Y; Bai X; Chen Y; Qian J; Zhu H; Liu F; Qiu X; Sun S; Ji N; Liu Y
    Oncotarget; 2017 Jul; 8(30):49156-49164. PubMed ID: 28467782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dramatic response of a BRAF V600E-mutated primary CNS histiocytic sarcoma to vemurafenib.
    Idbaih A; Mokhtari K; Emile JF; Galanaud D; Belaid H; de Bernard S; Benameur N; Barlog VC; Psimaras D; Donadieu J; Carpentier C; Martin-Duverneuil N; Haroche J; Feuvret L; Zahr N; Delattre JY; Hoang-Xuan K
    Neurology; 2014 Oct; 83(16):1478-80. PubMed ID: 25209580
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment of histiocytic sarcoma with cladribine and high-dose cytosine arabinoside in a child.
    Iwabuchi H; Kawashima H; Umezu H; Takachi T; Imamura M; Saitoh A; Ogose A; Imai C
    Int J Hematol; 2017 Aug; 106(2):299-303. PubMed ID: 28247189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of pediatric histiocytic sarcoma using abbreviated high-risk leukemia chemotherapy.
    Heath JL; Burgett SE; Gaca AM; Jaffe R; Wechsler DS
    Pediatr Blood Cancer; 2014 Oct; 61(10):1874-6. PubMed ID: 24888336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Would you think of histiocytic sarcoma in this fine-needle aspiration?
    Oliveira CC; Rocha JTQ; Silva GF; Biglia B; Gaiolla RD; Niero-Melo L; Domingues MAC
    Ann Hematol; 2018 Nov; 97(11):2257-2259. PubMed ID: 29728735
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antemortem diagnosis of localized central nervous system histiocytic sarcoma in 2 dogs.
    Tzipory L; Vernau KM; Sturges BK; Zabka TS; Highland MA; Petersen SA; Wisner ER; Moore PF; Vernau W
    J Vet Intern Med; 2009; 23(2):369-74. PubMed ID: 19192150
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary Orbital Histiocytic Sarcoma in a Child Successfully Treated With Multiagent Chemotherapy.
    Mittal N; Aakalu V; Mehendele S; Setabutr P; Michals E; Schmidt ML
    J Pediatr Hematol Oncol; 2016 Nov; 38(8):653-657. PubMed ID: 27467374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma.
    Voruz S; Cairoli A; Naveiras O; de Leval L; Missiaglia E; Homicsko K; Michielin O; Blum S
    Haematologica; 2018 Jan; 103(1):e39-e41. PubMed ID: 29097496
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical outcomes of patients with newly diagnosed primary central nervous system lymphoma are comparable on treatment with high-dose methotrexate plus temozolomide and with high-dose methotrexate plus cytarabine: a single-institution experience.
    Wang XX; Huang HQ; Bai B; Cai QQ; Cai QC; Gao Y; Xia YF; Xia ZJ; Jiang WQ
    Leuk Lymphoma; 2014 Nov; 55(11):2497-501. PubMed ID: 24605911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical efficacy of idarubicin combined with methotrexate for treatment of patients with central nervous system diffuse large B cell lymphoma].
    Yuan P; Yu ZP; Yue TH; Xiao YH; Chen BA
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1621-3. PubMed ID: 25543485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients.
    Ferreri AJ; Reni M; Dell'Oro S; Ciceri F; Bernardi M; Camba L; Ponzoni M; Terreni MR; Tomirotti M; Spina M; Villa E
    Oncology; 2001; 60(2):134-40. PubMed ID: 11244328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma. The GOELAMS LCP 99 trial.
    Olivier G; Clavert A; Lacotte-Thierry L; Gardembas M; Escoffre-Barbe M; Brion A; Cumin I; Legouffe E; Solal-Celigny P; Chabin M; Ingrand P; Colombat P; Delwail V
    Am J Hematol; 2014 Nov; 89(11):1024-9. PubMed ID: 25052698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Malignant histiocytosis: study of 8 cases].
    Fernández Miranda C; Martínez González MA; Ricard P; Ballestín C; Asso A; Hernández Martínez E; Guerra J; del Palacio A
    Med Clin (Barc); 1988 Mar; 90(11):437-42. PubMed ID: 2455200
    [No Abstract]   [Full Text] [Related]  

  • 18. [Malignant histiocytosis. Remission for more than 5 years].
    Lejeunne C; Degos L; Pol S; Hugues FC
    Presse Med; 1990 Feb; 19(5):218. PubMed ID: 2137919
    [No Abstract]   [Full Text] [Related]  

  • 19. Etoposide-based combination chemotherapy in malignant histiocytosis.
    Lin FR; Yao EG
    J Tongji Med Univ; 1994; 14(4):227-9. PubMed ID: 7760434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose methotrexate and temozolomide associated with intrathecal liposomal cytarabine for the treatment of primary or secondary central nervous system lymphoma: a preliminary experience.
    Falchi L; Gunnellini M; Ferranti L; Liberati AM
    Clin Neurol Neurosurg; 2012 Dec; 114(10):1376-8. PubMed ID: 22516417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.